Related references
Note: Only part of the references are listed.Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry
Jeremie Abtan et al.
CLINICAL CARDIOLOGY (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry
Jeremie Abtan et al.
CLINICAL CARDIOLOGY (2016)
Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry
Etienne Puymirat et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Cardiovascular disease in Europe - epidemiological update 2015
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2015)
Heart Disease and Stroke Statistics-2015 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2015)
Non-adherence to cardiovascular medications
Kumaran Kolandaivelu et al.
EUROPEAN HEART JOURNAL (2014)
2013 ESC guidelines on the management of stable coronary artery disease
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2013)
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
Jonas Oldgren et al.
EUROPEAN HEART JOURNAL (2011)
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
Gregory Ducrocq et al.
EUROPEAN HEART JOURNAL (2010)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Advancing the Care of Cardiac Patients Using Registry Data Going Where Randomized Clinical Trials Dare Not
Deepak L. Bhatt
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry
Mark J. Alberts et al.
EUROPEAN HEART JOURNAL (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Eligibility criteria of randomized controlled trials published in high-impact general medical journals - A systematic sampling review
Harriette G. C. Van Spall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
External validity of clinical trials in acute myocardial infarction
Philippe Gabriel Steg et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The REduction of Atherothrombosis for Continued Health (REACH) Registry:: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design
EM Ohman et al.
AMERICAN HEART JOURNAL (2006)
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
DL Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Share Paper
